Population pharmacokinetics of CPT-11 (irinotecan) in gastric cancer patients with peritoneal seeding after its intraperitoneal administration

被引:0
|
作者
Byung-Jin Ahn
Moon Ki Choi
Young Suk Park
Jeeyun Lee
Se Hoon Park
Joon Oh Park
Ho Yeong Lim
Won Ki Kang
Jae-Wook Ko
Dong-Seok Yim
机构
[1] Dongguk University,Medical Science Research Center
[2] Sungkyunkwan University School of Medicine,Division of Hematology
[3] Samsung Medical Center,Oncology, Department of Medicine, Samsung Medical Center
[4] The Catholic University of Korea,Department of Clinical Pharmacology & Therapeutics
关键词
Gastric cancer; CPT-11; Intraperitoneal administration; Pharmacokinetics; NONMEM;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1235 / 1245
页数:10
相关论文
共 50 条
  • [41] Phase II study of irinotecan (CPT-11) alone in patients (pts) with metastatic pancreatic cancer.
    Funakoshi, A
    Okusaka, T
    Ishii, H
    Sawaki, A
    Ohkawa, S
    Ishikawa, O
    Saitoh, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 338S - 338S
  • [42] POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF IRINOTECAN (CPT-11) AND ACTIVE METABOLITE SN-38 DURING PHASE-I TRIALS
    CHABOT, GG
    ABIGERGES, D
    CATIMEL, G
    CULINE, S
    DEFORNI, R
    EXTRA, JM
    MAHJOUBI, H
    HERAIT, P
    ARMAND, JP
    BUGAT, R
    CLAVEL, M
    MARTY, ME
    ANNALS OF ONCOLOGY, 1995, 6 (02) : 141 - 151
  • [43] Phase II study of carboplatin (CBDCA) and irinotecan (CPT-11) for patients with cancer of unknown primary (CUP)
    Ando, M., Sr.
    Yonemori, K.
    Yunokawa, M.
    Nakano, E.
    Kouno, T.
    Shimizu, C.
    Katsumata, N.
    Tamura, K.
    Arioka, H.
    Fujiwara, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [44] Prevention of irinotecan (CPT-11)-induced diarrhea by oral alkalization combined with control of defecation in cancer patients
    Takeda, Y
    Kobayashi, K
    Akiyama, Y
    Soma, T
    Handa, S
    Kudoh, S
    Kudo, K
    INTERNATIONAL JOURNAL OF CANCER, 2001, 92 (02) : 269 - 275
  • [45] Phase I dose finding study with irinotecan (CPT-11) in cancer patients (pts) with hepatic dysfunction
    Raymond, E
    Vernillet, L
    Boige, V
    Hua, A
    Ducreux, M
    Mekhaldi, S
    Jacques, C
    Gatineau, M
    Mignard, D
    Vergniol, JC
    Armand, JP
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S283 - S284
  • [46] Phase II study of CPT-11 plus CDDP in patients with metastatic gastric cancer
    Narahara, H
    Imamura, H
    Ikeda, M
    Kobayashi, K
    Fujitani, K
    Kato, M
    Iwamoto, H
    Takabayashi, A
    Tsukuma, H
    Tsujinaka, T
    Furukawa, H
    Taguchi, T
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 438 - 438
  • [47] CHEMOTHERAPY WITH CPT-11 AFTER GEMCITABINE FAILURE IN PATIENTS WITH ADVANCED PANCREATIC CANCER
    Kaneda, Hiroyasu
    Ueda, Shinya
    Makimura, Chihiro
    Kiyota, Hidemi
    Kawakami, Hisato
    Okamoto, Isamu
    Tanaka, Kaoru
    Nishina, Shinichi
    Kudo, Toshihiro
    Turutani, Junji
    Miyazaki, Masaki
    Fujisaka, Yasuhito
    Okamoto, Wataru
    Kurata, Takayasu
    Nakagawa, Kazuhiko
    ANNALS OF ONCOLOGY, 2012, 23 : 65 - 65
  • [48] Plasma pharmacokinetics of 7-ethyl-10-hydroxycamptothecin (SN-38) after intravenous administration of SN-38 and irinotecan (CPT-11) to rats
    Kaneda, N
    Hosokawa, Y
    Yokokura, T
    Awazu, S
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1997, 20 (09) : 992 - 996
  • [49] Population pharmacokinetics of intraperitoneal irinotecan and SN-38 in patients with peritoneal metastases from colorectal origin
    Rietveld, Pascale C. S.
    Sassen, Sebastiaan D. T.
    Guchelaar, Niels A. D.
    van Eerden, Ruben A. G.
    de Boer, Nadine L.
    van den Heuvel, Teun B. M.
    Burger, Jacobus W. A.
    Mathijssen, Ron H. J.
    Koch, Birgit C. P.
    Koolen, Stijn L. W.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (06): : 1006 - 1016
  • [50] Population pharmacokinetics of PEGylated liposomal CPT-11 (IHL-305) in patients with advanced solid tumors
    Wu, Huali
    Infante, Jeffrey R.
    Keedy, Vicki L.
    Jones, Suzanne F.
    Chan, Emily
    Bendell, Johanna C.
    Lee, Wooin
    Zamboni, Beth A.
    Ikeda, Satoshi
    Kodaira, Hiroshi
    Rothenberg, Mace L.
    Burris, Howard A., III
    Zamboni, William C.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (12) : 2073 - 2081